DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Ademetionine is an investigational drug.
There have been 5 clinical trials for Ademetionine. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2013.
The most common disease conditions in clinical trials are Liver Diseases, Alcoholic, Liver Diseases, and Cholestasis. The leading clinical trial sponsors are Beijing 302 Hospital, Ascent, and Zhejiang Hisun Pharmaceutical Co. Ltd.
There are six US patents protecting this investigational drug and one hundred and twenty-seven international patents.
Recent Clinical Trials for Ademetionine
|36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILI||Beijing 302 Hospital||Phase 1/Phase 2|
|Efficacy and Safety of Glucocorticosteroid Treatment in the Patients With Chronic Recurrent DILI||Beijing 302 Hospital||Phase 1/Phase 2|
|Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption||Ascent||Phase 3|
Top disease conditions for Ademetionine
Top clinical trial sponsors for Ademetionine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Ademetionine||Start Trial||Method for treating or preventing a functional vitamin B12 deficiency in an individual and medical compositions for use in said method||Cobalz Limited (Chester, Cheshire, GB)||Start Trial|
|Ademetionine||Start Trial||Pharmaceutical propylene glycol solvate compositions||McNeil-PPC, Inc. (Skillman, NJ)||Start Trial|
|Ademetionine||Start Trial||Pharmaceutical co-crystal compositions||University of South Florida (Tampa, FL) The Regents of the University of Michigan (Ann Arbor, MI) Transform Pharmaceuticals, Inc. (Lexington, MA)||Start Trial|
|Ademetionine||Start Trial||Microorganisms for producing propylene and methods related thereto||Genomatica, Inc. (San Diego, CA)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|